Graham Capital Management, L.P. Biogen Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 13,357 shares of BIIB stock, worth $1.83 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,357Holding current value
$1.83 Million% of portfolio
0.04%Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,007Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.29 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.2 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.99 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.01 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$506 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...